Variant report

Variant	esv1847946
Chromosome Location	chr13:30707385-30731192
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:485)
CpG islands
(count:488)
Chromatin interactive
region (count:21)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:485 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr13:30716418-30716958	GM12878	blood:	n/a	n/a
2	ATF2	chr13:30716441-30717002	GM12878	blood:	n/a	n/a
3	ATF2	chr13:30719963-30720650	GM12878	blood:	n/a	n/a
4	ATF2	chr13:30719812-30721127	GM12878	blood:	n/a	n/a
5	ATF2	chr13:30715067-30715488	GM12878	blood:	n/a	n/a
6	ATF3	chr13:30718277-30718404	K562	blood:	n/a	n/a
7	ATF3	chr13:30718192-30718533	GM12878	blood:	n/a	n/a
8	ATF3	chr13:30718260-30718406	GM12878	blood:	n/a	n/a
9	BATF	chr13:30720016-30720589	GM12878	blood:	n/a	chr13:30720253-30720262
10	BATF	chr13:30715602-30715845	GM12878	blood:	n/a	n/a
11	BATF	chr13:30715122-30715507	GM12878	blood:	n/a	n/a
12	BATF	chr13:30716370-30716820	GM12878	blood:	n/a	n/a
13	BATF	chr13:30719898-30720629	GM12878	blood:	n/a	chr13:30720253-30720262
14	BATF	chr13:30715139-30715414	GM12878	blood:	n/a	n/a
15	BCL11A	chr13:30715050-30715432	GM12878	blood:	n/a	n/a
16	BCL11A	chr13:30720090-30720423	GM12878	blood:	n/a	chr13:30720267-30720276
17	BCL11A	chr13:30720023-30720600	GM12878	blood:	n/a	chr13:30720267-30720276
18	BCL3	chr13:30720008-30720550	GM12878	blood:	n/a	chr13:30720267-30720276
19	BCLAF1	chr13:30719835-30720617	GM12878	blood:	n/a	chr13:30720267-30720276
20	BCLAF1	chr13:30719944-30720582	GM12878	blood:	n/a	chr13:30720267-30720276
21	BCLAF1	chr13:30720721-30721128	GM12878	blood:	n/a	n/a
22	BHLHE40	chr13:30716971-30717259	GM12878	blood:	n/a	n/a
23	BHLHE40	chr13:30712184-30712384	HepG2	liver:	n/a	n/a
24	BHLHE40	chr13:30715141-30715441	GM12878	blood:	n/a	n/a
25	BHLHE40	chr13:30716563-30716769	GM12878	blood:	n/a	n/a
26	BHLHE40	chr13:30712174-30712407	K562	blood:	n/a	n/a
27	BHLHE40	chr13:30712318-30712352	GM12878	blood:	n/a	n/a
28	BHLHE40	chr13:30720079-30720470	GM12878	blood:	n/a	n/a
29	CCNT2	chr13:30707716-30707908	K562	blood:	n/a	n/a
30	CEBPB	chr13:30717893-30718099	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr13:30727156-30727215	HepG2	liver:	n/a	n/a
32	CEBPB	chr13:30719935-30720176	K562	blood:	n/a	chr13:30720068-30720077 chr13:30720067-30720078 chr13:30720066-30720079 chr13:30720068-30720077 chr13:30720068-30720077 chr13:30720068-30720077
33	CEBPB	chr13:30716482-30717138	GM12878	blood:	n/a	n/a
34	CEBPB	chr13:30717830-30718193	IMR90	lung:	n/a	n/a
35	CEBPB	chr13:30711962-30712486	Hela-S3	cervix:	n/a	chr13:30712085-30712096
36	CEBPB	chr13:30719858-30720703	GM12878	blood:	n/a	chr13:30720068-30720077 chr13:30720067-30720078 chr13:30720066-30720079 chr13:30720068-30720077 chr13:30720068-30720077 chr13:30720068-30720077
37	CEBPB	chr13:30711985-30712454	IMR90	lung:	n/a	chr13:30712085-30712096
38	CEBPB	chr13:30716486-30717391	IMR90	lung:	n/a	n/a
39	CEBPB	chr13:30711984-30712182	HepG2	liver:	n/a	chr13:30712085-30712096
40	CEBPB	chr13:30719933-30720152	HepG2	liver:	n/a	chr13:30720068-30720077 chr13:30720067-30720078 chr13:30720066-30720079 chr13:30720068-30720077 chr13:30720068-30720077 chr13:30720068-30720077
41	CHD2	chr13:30716607-30716856	GM12878	blood:	n/a	n/a
42	CTCF	chr13:30721560-30721710	GM12868	blood:	n/a	n/a
43	CTCF	chr13:30717120-30717270	AG10803	skin:	n/a	n/a
44	CTCF	chr13:30717080-30717230	HFF-Myc	foreskin:	n/a	n/a
45	CTCF	chr13:30721640-30721790	GM12871	blood:	n/a	n/a
46	CTCF	chr13:30715298-30715317	Kidney_OC	kidney:	n/a	n/a
47	CTCF	chr13:30721674-30721752	GM10248	blood:	n/a	n/a
48	CTCF	chr13:30721653-30721757	GM10266	blood:	n/a	n/a
49	CTCF	chr13:30721800-30721950	GM12864	blood:	n/a	n/a
50	CTCF	chr13:30721561-30721850	GM12878	blood:	n/a	n/a

(count:488 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr13:30728812-30728862	IMR90	lung:	fetal
2	chr13:30728819-30728869	ECC-1	luminal epithelium:	n/a
3	chr13:30717380-30717430	HCPEpiC	choroid plexus:	n/a
4	chr13:30728812-30728862	HCM	heart:	n/a
5	chr13:30728812-30728862	MCF10A-Er-Src	breast:	n/a
6	chr13:30728812-30728862	T-47D	breast:	n/a
7	chr13:30707585-30707635	HPAEpiC	pulmonary alveolar:	n/a
8	chr13:30717380-30717430	MCF-7	breast:	n/a
9	chr13:30707585-30707635	PrEC	prostate:	n/a
10	chr13:30707585-30707635	IMR90	lung:	fetal
11	chr13:30728812-30728862	HIPEpiC	eye:	n/a
12	chr13:30717380-30717430	AG10803	skin:	n/a
13	chr13:30728534-30728584	RPTEC	kidney:	n/a
14	chr13:30728236-30728286	K562	blood:	n/a
15	chr13:30728812-30728862	GM12891	blood:	n/a
16	chr13:30728812-30728862	NHDF-neo	bronchial:	n/a
17	chr13:30728534-30728584	GM12891	blood:	n/a
18	chr13:30728099-30728149	AG10803	skin:	n/a
19	chr13:30728819-30728869	HEK293	kidney:	embryo
20	chr13:30728812-30728862	HEEpiC	esophagus:	n/a
21	chr13:30728819-30728869	AG10803	skin:	n/a
22	chr13:30728819-30728869	HMEC	breast:	n/a
23	chr13:30728534-30728584	HCM	heart:	n/a
24	chr13:30727927-30727977	HCM	heart:	n/a
25	chr13:30728236-30728286	HCT-116	colon:	n/a
26	chr13:30707585-30707635	PFSK-1	brain:	n/a
27	chr13:30707585-30707635	HCM	heart:	n/a
28	chr13:30707585-30707635	MCF10A-Er-Src	breast:	n/a
29	chr13:30707585-30707635	HAEpiC	amniotic membrane:	n/a
30	chr13:30717380-30717430	SK-N-SH	brain:	n/a
31	chr13:30728534-30728584	CMK	blood:	n/a
32	chr13:30728534-30728584	GM06990	blood:	n/a
33	chr13:30728812-30728862	A549	lung:	n/a
34	chr13:30728819-30728869	NHDF-neo	bronchial:	n/a
35	chr13:30728534-30728584	Hela-S3	cervix:	n/a
36	chr13:30728819-30728869	Caco-2	colon:	n/a
37	chr13:30728534-30728584	GM12892	blood:	n/a
38	chr13:30717380-30717430	HRE	kidney:	n/a
39	chr13:30707585-30707635	HUVEC	blood vessel:	n/a
40	chr13:30728534-30728584	ProgFib	skin:	n/a
41	chr13:30728534-30728584	PANC-1	pancreas:	n/a
42	chr13:30727927-30727977	AoSMC	blood vessel:	n/a
43	chr13:30728099-30728149	GM12891	blood:	n/a
44	chr13:30728236-30728286	AG09319	gingival:	n/a
45	chr13:30728534-30728584	SAEC	small airway:	n/a
46	chr13:30727927-30727977	GM12891	blood:	n/a
47	chr13:30727927-30727977	CMK	blood:	n/a
48	chr13:30727927-30727977	BJ	skin:	n/a
49	chr13:30728534-30728584	NT2-D1	testis:	n/a
50	chr13:30728099-30728149	GM12878	blood:	n/a

(count:21 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr13:30710819..30713785-chr13:31038397..31039974,2	MCF-7	breast:
2	chr13:30707361..30710289-chr13:30714464..30717739,4	MCF-7	breast:
3	chr13:30720797..30723795-chr8:43093825..43096195,3	MCF-7	breast:
4	chr13:30727286..30729664-chr13:30729763..30731896,2	MCF-7	breast:
5	chr13:30718966..30721747-chr13:30731503..30734403,2	MCF-7	breast:
6	chr13:30709420..30711162-chr13:30732308..30734372,2	MCF-7	breast:
7	chr13:30720797..30722317-chr8:43092931..43095226,2	K562	blood:
8	chr13:30708914..30710508-chr13:30839342..30841518,2	MCF-7	breast:
9	chr13:30698648..30700274-chr13:30705836..30708500,2	MCF-7	breast:
10	13:30704196-30711562..13:30879528-30882380	H1-hESC	embryonic stem cell:	embryo
11	chr13:30710616..30714136-chr13:30716937..30719066,3	K562	blood:
12	chr13:30716922..30719833-chr13:30752505..30754476,2	MCF-7	breast:
13	chr13:30707361..30710289-chr13:30714464..30717739,4	MCF-7	breast:
14	chr13:30702300..30704333-chr13:30714151..30716262,2	K562	blood:
15	chr13:30706815..30707417-chr13:30908978..30909886,3	MCF-7	breast:
16	chr13:30710616..30714136-chr13:30716937..30719066,3	K562	blood:
17	chr13:30690726..30692990-chr13:30715205..30717386,2	MCF-7	breast:
18	chr13:30721961..30724488-chr13:30755473..30758076,2	K562	blood:
19	chr13:30697642..30699768-chr13:30715433..30718388,2	MCF-7	breast:
20	chr13:30706898..30707420-chr13:30908752..30909540,2	MCF-7	breast:
21	chr13:30705361..30707918-chr13:31032869..31034442,2	K562	blood:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KATNAL1-2	chr13:30727171-30733758	XLOC_010554
2	lnc-KATNAL1-2	chr13:30726023-30726286	XLOC_010554
3	lnc-RP11-90M5.1.1-3	chr13:30728426-30728723	ENSG00000232643
4	lnc-RP11-90M5.1.1-3	chr13:30728203-30728278	ENSG00000232643
5	lnc-RP11-90M5.1.1-3	chr13:30727850-30727977	NONHSAT032767
6	lnc-RP11-90M5.1.1-3	chr13:30728426-30729034	NONHSAT032767

No data

Variant related genes	Relation type
LINC00385	TF binding region
LINC00385	CpG island
ENSG00000232117	chromatin interactions
ENSG00000102781	chromatin interactions
ENSG00000189403	chromatin interactions
ENSG00000232643	chromatin interactions

Extended variants
information (count: 955 )
Associated
traits (count: 88 )

Variant overlapped rSNPs/rCNVs (count:955 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs575731332	chr13:30707417-30707418	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs641545	chr13:30707436-30707437	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
3	rs150756764	chr13:30707480-30707481	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs148953782	chr13:30707527-30707528	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs565557829	chr13:30707538-30707539	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs535220510	chr13:30707554-30707555	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs139030497	chr13:30707601-30707602	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs574895190	chr13:30707610-30707611	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs533993804	chr13:30707692-30707693	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs537184846	chr13:30707696-30707697	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs557015493	chr13:30707710-30707711	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs576874184	chr13:30707717-30707718	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs369242900	chr13:30707723-30707724	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs375116455	chr13:30707729-30707730	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs555423711	chr13:30707741-30707742	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs113715059	chr13:30707757-30707758	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs545784698	chr13:30707801-30707802	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs564021641	chr13:30707811-30707812	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs559232697	chr13:30707814-30707815	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs643621	chr13:30707853-30707854	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
21	rs542023293	chr13:30707879-30707880	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs531266	chr13:30707903-30707904	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs192749013	chr13:30707926-30707927	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs184643521	chr13:30707946-30707947	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs149878441	chr13:30707949-30707950	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs113957823	chr13:30707975-30707976	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs189963565	chr13:30707980-30707981	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs566395333	chr13:30707992-30707993	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs578167355	chr13:30708003-30708004	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs545719736	chr13:30708074-30708075	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs181685248	chr13:30708079-30708080	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs548850732	chr13:30708111-30708112	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs568591126	chr13:30708128-30708129	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs537650964	chr13:30708130-30708131	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs549276850	chr13:30708139-30708140	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs575676528	chr13:30708144-30708145	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs557074769	chr13:30708167-30708168	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs142288510	chr13:30708190-30708191	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs184486216	chr13:30708227-30708228	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs200002838	chr13:30708247-30708248	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs9506266	chr13:30708254-30708255	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
42	rs74043021	chr13:30708266-30708267	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs541785323	chr13:30708303-30708304	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs506517	chr13:30708331-30708332	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs386769578	chr13:30708343-30708344	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs9783564	chr13:30708344-30708345	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs144379897	chr13:30708348-30708349	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs656305	chr13:30708378-30708379	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
49	rs543279953	chr13:30708389-30708390	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs56244909	chr13:30708406-30708407	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:88)

Disease	PMID	Source
Cancer	20164920	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	18698080	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Squamous cell cancer	20885788	CNVD
Thyroid cancer	19087340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Malignant glioma	17146433	CNVD
Breast cancer	17899364	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	16774939	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	18179710	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Myelofibrosis	22110671	CNVD
Non-small cell lung cancer	21829676	CNVD
Retinoblastoma	22278416	CNVD
Peters Plus syndrome	16909395	CNVD
Trisomy	24170809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Breast cancer	20031965	CNVD
Colorectal cancer	19287155	CNVD
Ovarian cancer	19047089	CNVD
Alveolar rhabdomyosarcoma	16790082	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
Prostate cancer	18632612	CNVD
Prostate cancer	21147910	CNVD
Schizophrenia	23813976	CNVD
Breast cancer	22522925	CNVD
Congenital anomalies of the kidney and urinary tract	17440070	CNVD
Cancer	17440070	CNVD

Chromatin state (count:544 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:30700200-30708000	Weak transcription	NH-A	brain
2	chr13:30700200-30717200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
3	chr13:30706400-30707800	Enhancers	Dnd41	blood
4	chr13:30706400-30709400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
5	chr13:30706600-30707400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
6	chr13:30706600-30707400	Enhancers	Liver	Liver
7	chr13:30706600-30707600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr13:30706600-30707600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
9	chr13:30706600-30707600	Enhancers	Primary T regulatory cells fromperipheralblood	blood
10	chr13:30706600-30708400	Enhancers	Fetal Thymus	thymus
11	chr13:30706600-30708800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
12	chr13:30706600-30708800	Enhancers	Stomach Mucosa	stomach
13	chr13:30706600-30709000	Enhancers	Brain Hippocampus Middle	brain
14	chr13:30706600-30709000	Enhancers	Brain Substantia Nigra	brain
15	chr13:30706600-30709200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
16	chr13:30706600-30709200	Enhancers	Fetal Intestine Small	intestine
17	chr13:30706800-30707400	Enhancers	Primary B cells from peripheral blood	blood
18	chr13:30706800-30707400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
19	chr13:30706800-30707400	Enhancers	Esophagus	oesophagus
20	chr13:30706800-30707400	Enhancers	Skeletal Muscle Female	skeletal muscle
21	chr13:30706800-30707600	Enhancers	Primary T helper cells PMA-I stimulated	--
22	chr13:30706800-30707600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
23	chr13:30706800-30707600	Enhancers	Primary T killer naive cells fromperipheralblood	blood
24	chr13:30706800-30707600	Enhancers	Brain Germinal Matrix	brain
25	chr13:30706800-30707600	Enhancers	Duodenum Smooth Muscle	Duodenum
26	chr13:30706800-30708000	Enhancers	Primary T cells fromperipheralblood	blood
27	chr13:30706800-30708600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr13:30706800-30708600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
29	chr13:30706800-30708600	Enhancers	Fetal Muscle Leg	muscle
30	chr13:30706800-30709600	Enhancers	Adipose Nuclei	Adipose
31	chr13:30707000-30707400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
32	chr13:30707000-30707400	Enhancers	Primary T cells from cord blood	blood
33	chr13:30707000-30707400	Enhancers	Primary hematopoietic stem cells	blood
34	chr13:30707000-30707400	Enhancers	Primary hematopoietic stem cells short term culture	blood
35	chr13:30707000-30707400	Enhancers	Primary T helper naive cells from peripheral blood	blood
36	chr13:30707000-30707400	Enhancers	Primary T killer memory cells from peripheral blood	blood
37	chr13:30707000-30707400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
38	chr13:30707000-30707400	Bivalent Enhancer	Placenta	Placenta
39	chr13:30707000-30707400	Enhancers	Left Ventricle	heart
40	chr13:30707000-30707400	Flanking Active TSS	Stomach Smooth Muscle	stomach
41	chr13:30707000-30707400	Enhancers	Thymus	Thymus
42	chr13:30707000-30707400	Enhancers	Spleen	Spleen
43	chr13:30707000-30707400	Enhancers	GM12878-XiMat	blood
44	chr13:30707000-30707600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
45	chr13:30707000-30707600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
46	chr13:30707000-30707600	Flanking Active TSS	Duodenum Mucosa	Duodenum
47	chr13:30707000-30707600	Enhancers	Sigmoid Colon	Sigmoid Colon
48	chr13:30707000-30707800	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
49	chr13:30707000-30707800	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
50	chr13:30707000-30708000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links